News about University Research Park tenants.
If you have a news article or announcement you'd like considered for our news room, please e-mail a copy of the article to promeo@wisc.edu.
January 29, 2012
Stemina Biomarker Discovery Inc. uses a proprietary stem cell technology that allows it to predict with a high degree of accuracy whether a drug or a compund is going to be toxic.
January 12, 2012
InvivoSciences, LLC and Myomics, Inc. (Providence, RI) announce a corporate partnership to provide high content compound screening services using 3D engineered tissue.
January 11, 2012
Aberdean Consulting, LLC, of Madison has acquired the client list of Sundial Software Corp.'s small business support service for undisclosed terms. Two Sundial employees familiar with the client list will join Aberdean as a result. Founded in 2003, Aberdean provides IT solutions and services to small and mid-sized businesses.
December 14, 2011
Nu Skin Enterprises, a Provo, Utah, company that sells anti-aging products, has completed the purchase of LifeGen Technologies, located at University Research Park, for $11.7 million.
December 13, 2011
Cellular Dynamics International is out with a new product: stem cell-derived neurons. It is the first commercial release of human brain cells, created through the company's stem cell technology, in large enough quantity, quality and purity for use in life science research.
November 1, 2011
Lynn Allen-Hoffmann's company recently embarked on second multi-center clinical trial of the company’s StrataGraft living skin substitute. The trial will assess the safety and clinical use of the skin substitute in the long-term treatment of patients with severe second-degree burns.
October 31, 2011
Madison-based Stratatech Corp. is getting a $4.6 million grant to help fund the start of clinical trials of ExpressGraft, a skin substitute designed to heal diabetes-related foot ulcers.
October 24, 2011
Roche Madison, formerly part of Mirus Bio Corp., has been purchased by Arrowhead Research Corp. of Pasadena, California.
October 17, 2011
Cellular Dynamics International, the stem cell company founded by UW-Madison researcher James Thomson in 2004, has won the top prize in the Wall Street Journal's 2011 Technology Innovation Awards.
October 11, 2011
Zurex PharmAgra, LLC (PharmAgra) launched its first product offering, the ZuraLac™ family of teat treatments, at the 2011 World Dairy Expo in Madison, Wisconsin.
October 11, 2011
Zurex PharmAgra, LLC (PharmAgra) launched its first product offering, the ZuraLacä family of teat treatments, at the 2011 World Dair Expo in Madison, Wisconsin.
September 23, 2011
Stratatech Corp., a leader in regenerative medicine, announced that it has initiated its second multicenter clinical trial of the company's StrataGraft® skin substitute. The clinical trial will assess the safety and clinical utility of the StrataGraft® skin substitute in the long-term treatment of patients with severe second-degree burns.
September 20, 2011
Cellular Dynamics International, Inc., a Madison industrial manufacturer of human-induced pluripotent stem cells and tissue cells, has announced the commercial launch of its human iCell Endothelial cells for use in vascular-targeted drug discovery, tissue regeneration and other life science research.
August 30, 2011
IBmadison.com named Jamie Barger as Professional of the Week - August 30, 2011. Read about Jamie and LifeGen Technologies, LLC in the wonderful interview. Congratulations Jamie!
August 10, 2011
As scientists and engineers explore the unknown, they frequently end up building the cutting-edge equipment and instruments they need, and high-tech instrument makers that have emerged from UW-Madison labs have been a good foundation for spinoff firms that sell research tools and equipment globally while creating a wide range of jobs in Wisconsin.
July 26, 2011
Tektronix, Inc., a leading supplier of test, measurement, and monitoring products and solutions, today announced the acquisition of Optametra, LLC.
July 12, 2011
Mirus Bio has initiated the Mirus Research Award Program to recognize the excellent research being conducted in the face of continued national grant funding reductions and decreased R&D budgets.
July 5, 2011
Cellular Dynamics International and the Medical College of Wisconsin have received a five-year, $6.26 million grant from the National Heart, Lung and Blood Institute.
July 5, 2011
The Medical College of Wisconsin, Wauwatosa and Cellular Dynamics International Inc., the Madison biotechnology firm founded by stem cell pioneer and University of Wisconsin-Madison researcher James Thomson, have been awarded a $6.26 million federal grant to generate stem cell lines for heart disease research.
June 14, 2011
Madison, WI. Primorigen Biosciences, Inc. has entered into an
exclusive worldwide distribution agreement with STEMCELL Technologies,
Inc., of Vancouver, British Columbia, Canada. The agreement covers
distribution of StemAdhere(TM), a new cell adhesion product developed
and manufactured by Primorigen that promotes stem cell growth and
pluripotency—the ability to become any cell type. The product is
designed as a tool to help researchers focused on reversing conditions
such as diabetes, Alzheimer’s Disease and other degenerative diseases.
June 13, 2011
Zurex PharmAgra LLC, a Madison biotech company, has been certified as a qualified new business venture by the state Department of Commerce, a move that makes its investors eligible for tax credits.
June 8, 2011
Cellular Dynamics International Inc. said that it has forged an agreement with a Japanese company to distribute its stem-cell derived heart cells.
May 25, 2011
Local Dirt, located at the Metro Innovation Center, connects small farmers and stores, restaurants and consumers. It serves tens of thousands of customers and allows farmers to post their own inventory, which is updated as customers place orders.
May 20, 2011
WisBusiness.com The Show features an interview with President & CEO Carmine Durham from Zurex Pharma.
More information at:
May 20, 2011
Governor Walker visited Zurex Pharma and BioSentinel Pharmaceuticals to discuss the need for venture capital for start-up companies.
May 9, 2011
Mithridion, a Madison drug development company, has received orphan drug designation for its leading compound, MCD-386CR.
May 6, 2011
The Committee for Medicinal Products for Veterinary Use (CVMP) adopted a positive opinion, recommending the granting of a marketing authorization for the veterinary medicinal product Recuvyra, 50 mg/ml transdermal solution, intended for the control of post-operative pain in dogs. The applicant for this veterinary medicinal product is Procyon Pharmaceutical Ltd., now named Nexcyon.
May 2, 2011
Zurex Pharma Inc., with a unique infection-fighting technology, has raised $1 million in venture capital from Peak Ridge AgTech Fund. Zurex's technology has "tremendous potential" to prevent infections humans acquire in health care settings as well as dairy mastitis, said Jason Smith, a general partner in the AgTech Fund.
April 7, 2011
Cellular Dynamics, known as CDI, will use the latest investments to launch new stem cell lines and increase production capacity, said Robert Palay, chairman and chief executive officer.
April 5, 2011
ProCertus BioPharm, a pharmaceutical company developing therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy, has closed on an additional $1.7 million round of financing.
March 30, 2011
Functional Biosciences, Inc., has been recognized as one of the thirty-three 2011 "Wisconsin Companies to Watch," an awards program presented by the Wisconsin Entrepreneurs' Network (WEN) with support from the Wisconsin SBDC Network and the Division of Entrepreneurship and Economic Development (DEED) at the University of Wisconsin-Extension in association with Edward Lowe Foundation.
March 29, 2011
Cell Line Genetics, Functional Biosciences, and ScheduleSoft Corp., were three University Research Park companies that have been named Wisconsin Companies to Watch in 2011.
March 29, 2011
To further expand the Wisconsin Idea and construct new tools for research and development in the education field, University of Wisconsin officials announced Monday a new institution that will allow university faculty and graduate students opportunities to provide greater resources for students.
The Wisconsin Center for Education Products and Services, which will be located at the University Research Park, will help license and distribute copyrighted material created by UW faculty and graduate students, WCEPS Board of Directors Chairman Brad Taylor said.
March 23, 2011
Stratatech, an MGE Innovation Center company developing skin substitutes for wound healing, is one of the Madison area companies that has been successful turning technology ideas into a business. Stratatech has received more than $14 million in SBIR and STTR grants from the National Institutes of Health alone.
March 22, 2011
Cellular Dynamics International says its two-year collaboration with Roche has turned into a full-fledged supply contract.
February 22, 2011
An app, which is currently being developed by Madison's SnowShoeFood, LLC, makes clever use of smart phone technology to give consumers an idea of how their simple food purchases influence climate change, which scientists say is caused by the release of greenhouse gases such as carbon dioxide.
February 21, 2011
FluGen, an emerging biosciences company co-founded by University of Wisconsin-Madison influenza experts, has landed $7.8 million of funding that will carry one of its leading technologies into human clinical trials this year.
February 17, 2011
CIT - Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced today that CIT and Stemina have entered into a strategic partnership. Under the arrangement, CIT will distribute Stemina's devTOX™ assay in Europe and will work with Stemina to validate the test for use under the REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) initiative.
